EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 30th, 2024
This exclusive license agreement (“Agreement”) is made effective this 22nd day of March, 2022 (“Effective Date”), by and between The Regents of the University of California, a California public corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200 (“The Regents”), acting through The Technology Development Group of the University of California, Los Angeles (“UCLA”), located at 10889 Wilshire Boulevard, Suite 920, Los Angeles, CA 90095-7191, and Radiopharm Theranostics Limited. (“Licensee”), having a principal place of business at 101/50 McLachlan Avenue, Rushcutters Bay 2011 NSW, Australia.